Search results for " costs"
Article
Eliminating Residual Impurities Starts with a Strategic Plan
“Realizing only at or after a biologics license application submission that the data package is not sufficient might endanger commercialization with a much higher financial impact compared to the cost…
Article
Addressing mAb Purification Bottlenecks with Rapid Cycling Chromatography
Fibro chromatography is a recently launched chromatography platform that enables purification cycles in minutes rather than hours. The rapid purification enables higher throughput in research and pr…
Article
The Future of Biopharma
In this article, Günter Jagschies, former Senior Director, Strategic Consumer Relations at Cytiva, highlights the evolution of the biopharma industry. Günter discuss challenges and opportunities for…
Article
Flexible Facilities for Viral Vector Manufacturing
Increased biosafety level classification adds manufacturing and facility complexity and costs.”
Range of scales
Makowiecki says that many new facilities today are designed to use single-use …
Article
Maximizing the Effectiveness of Upstream Bioprocessing Through the Combination of Lab Informatics and Instrumentation
By establishing effective management of data and knowledge, it will be possible to employ advances, such as artificial intelligence and synthetic biology, to their full potential in upstream bioproc…
Article
2019’s Top Bioprocessing Trends and What to Expect in 2020
2019 proved to be an exciting year for biopharmaceutical developers and process engineers, filled with both advancements and lessons. Considering how far the industry has come, what direction will 2…
Article
Biosimilar Quality Requirements
…angeable products, increasing access to life-saving medications, and potentially lowering healthcare costs through competition. Because of patient need, well-functioning biosimilar and interchangeabl…
Article
Driving Improved Access to Biosimilars
Driving Improved Access to Biosimilars
New guidance from FDA, including standards for interchangeability, is expected to speed development of biosimilars, but experts warn against oversimplifying ri…
Article
Four Steps Toward End-to-End Connected Manufacturing
Reduce costs and increase efficiencies by implementing continuous biomanufacturing strategies into upcoming processes. Continuous biomanufacturing is a key step toward promoting drug quality and imp…
Article
Design Considerations for a Commercial Cell and Gene Therapy Facility
The commercialization of cell and gene therapies has become a reality, prompting deeper considerations of logistics, technology, and design for manufacturing facilities.
By Feliza Mirasol
…